TNON Tenon Medical, Inc. - Common Stock
TNON Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
TNON Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
TNON Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 25.0%
- Buy 5 62.5%
- Hold 1 12.5%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-08-14Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-12.35 | $-8.57 | -3.8% |
| March 31, 2026 | $-10.85 | $-10.89 | 0.04% |
| Dec. 31, 2025 | $-13.30 | $-12.85 | -0.45% |
| Sept. 30, 2025 | $-0.40 | $-0.38 | -0.02% |
| June 30, 2025 | $-0.36 | $-0.48 | 0.12% |
| March 31, 2025 | $-1.01 | $-1.13 | 0.12% |
| Dec. 31, 2024 | $-2.54 | $-2.59 | 0.05% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TNON | — | — | — | — | — | — |
| FEED | $3M | -0.1 | -0.20% | -712.3% | -49.2% | 6.0% |
| GCTK | $4M | 0.1 | — | — | -399.4% | — |
| IVF | — | -0.0 | 4.7% | — | — | — |
| AEMD | $3M | -0.2 | — | — | -134.5% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 19 filers · $351K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (+7 vs prior Q) | 0 (-5 vs prior Q) | 2 (-1 vs prior Q) | 3 (+2 vs prior Q) | +721K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Warberg Asset Management LLC | $140,442 | 430,407 | 40.03% | Shares |
| VANGUARD GROUP INC | $68,273 | 71,715 | 19.46% | Shares |
| ARMISTICE CAPITAL, LLC | $56,158 | 172,105 | 16.00% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $23,379 | 71,715 | 6.66% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $20,454 | 62,686 | 5.83% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $14,549 | 44,628 | 4.15% | Shares |
| SBI Securities Co., Ltd. | $12,962 | 39,725 | 3.69% | Shares |
| NORTHERN TRUST CORP | $10,129 | 31,043 | 2.89% | Shares |
| Spectrum Asset Management, Inc. (NB/CA) | $3,476 | 10,650 | 0.99% | Shares |
| CITIGROUP INC | $564 | 1,730 | 0.16% | Shares |
| Tower Research Capital LLC (TRC) | $299 | 915 | 0.09% | Shares |
| FIDUCIARY FINANCIAL ADVISORS | $62 | 190 | 0.02% | Shares |
| MORGAN STANLEY | $61 | 188 | 0.02% | Shares |
| Clear Street Group Inc. | $33 | 100 | 0.01% | Shares |
| HRT FINANCIAL LP | $27 | 84,605 | 0.01% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $8 | 24 | 0.00% | Shares |
| Allworth Financial LP | $7 | 20 | 0.00% | Shares |
| UBS Group AG | $1 | 4 | 0.00% | Shares |
| AlphaMark Advisors, LLC | $0 | 50 | 0.00% | Shares |
Company insiders 11 insiders · 6 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Steven M Foster | CEO and President | Jan. 1, 2026 M | 163,814 | 0 | 0 | $0 |
| Kevin Williamson | Chief Financial Officer | March 3, 2026 M | 43,593 | 0 | 0 | $0 |
| Steven M Van Dick | Chief Financial Officer | June 14, 2023 P | 100,416 | 0 | 0 | $0 |
| Nathaniel A. Grawey | Chief Commercial Officer | May 1, 2026 A | 243,584 | 0 | 0 | $0 |
| Wyatt D. Geist | Chief Innovation Officer | May 1, 2026 A | 487,166 | 0 | 0 | $0 |
| Richard Ginn | Chief Technology Officer | Jan. 1, 2026 M | 85,589 | 0 | 0 | $0 |
| Kristine M Jacques | Director | Jan. 1, 2026 M | 10,729 | 0 | 0 | $0 |
| Robert K Weigle | Director | Jan. 1, 2026 M | 7,552 | 0 | 0 | $0 |
| Ivan Howard | Director | Jan. 1, 2026 M | 8,462 | 0 | 0 | $0 |
| Stephen Hochschuler | Director | Jan. 1, 2026 M | 7,938 | 0 | 0 | $0 |
| Richard Ferrari | Director | Jan. 1, 2026 M | 70,764 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| SiVantage Inc. | Aug. 8, 2025 | 12.50% | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 71,715 SH | Aug. 8, 2026 | Daily |